Most folks are familiar with the havoc that high pollen levels can wreak on their lungs, but new research suggests they can also exacerbate a painful pelvic condition in some people.
About JAMA Network Open:
JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.
Share
Health leaders thankful flu in check during COVID-19 crisis
January 8, 2021 GMT
ST. LOUIS (AP) As coronavirus cases surge in Missouri and across the U.S., public health officials are thankful that, so far, the flu has remained largely in check.
Health leaders worried about a possible “twindemic” as the severe flu season began in the late fall, something that would leave patients with the flu and COVID-19 competing for ventilators and hospital beds.
Missouri’s influenza report shows that by Dec. 26, 2020, 681 people had tested positive for influenza the lowest total by that time of year in at least the last six flu seasons, The St. Louis Post-Dispatch reported Friday. Typically, case numbers by the end of December have averaged just under 13,000.
Fauci to deliver virtual COVID-19 lecture to Washington University students missourinet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from missourinet.com Daily Mail and Mail on Sunday newspapers.
India could get nasal vaccine against Covid-19 soon, trials set to begin in Nagpur
India could get nasal vaccine against Covid-19 soon, trials set to begin in Nagpur
Bharat Biotech, whose Covaxin vaccine has already received emergency use approval, has said that the trial of a nasal variant of Covid-19 vaccine could begin in Nagpur in the next two weeks. Bharat Biotech to submit a proposal to DCGI soon.
advertisement
(Representational image. Photo: AFP)
A nasal Covid-19 vaccine could be a reality in India soon with Bharat Biotech, the Indian vaccine maker, all set to start phase 1 and 2 trials of a nasal vaccine at Gillurkar Multi Speciality Hospital in Nagpur.